AbCellera Biologics (ABCL) Asset Utilization Ratio (2021 - 2024)
Historic Asset Utilization Ratio for AbCellera Biologics (ABCL) over the last 4 years, with Q3 2024 value amounting to 0.01.
- AbCellera Biologics' Asset Utilization Ratio fell 8020.02% to 0.01 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.01, marking a year-over-year decrease of 8020.02%. This contributed to the annual value of 0.02 for FY2024, which is 1937.28% down from last year.
- As of Q3 2024, AbCellera Biologics' Asset Utilization Ratio stood at 0.01, which was down 8020.02% from 0.01 recorded in Q2 2024.
- In the past 5 years, AbCellera Biologics' Asset Utilization Ratio registered a high of 0.4 during Q1 2021, and its lowest value of 0.01 during Q3 2024.
- Over the past 4 years, AbCellera Biologics' median Asset Utilization Ratio value was 0.3 (recorded in 2021), while the average stood at 0.21.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 419.23% in 2022, then tumbled by 9192.36% in 2023.
- Quarter analysis of 4 years shows AbCellera Biologics' Asset Utilization Ratio stood at 0.3 in 2021, then increased by 4.19% to 0.31 in 2022, then crashed by 91.92% to 0.03 in 2023, then crashed by 74.18% to 0.01 in 2024.
- Its last three reported values are 0.01 in Q3 2024, 0.01 for Q2 2024, and 0.02 during Q1 2024.